Navigation Links
Dendreon Announces Presentation of PROVENGE Data at the 2011 American Society of Clinical Oncology Annual Meeting
Date:5/18/2011

SEATTLE, May 18, 2011 /PRNewswire/ -- Dendreon Corporation (Nasdaq: DNDN) today announced the following PROVENGE® (sipuleucel-T) data presentations taking place at the 2011 American Society of Clinical Oncology annual meeting in Chicago, Illinois.

  • "Time to Disease-Related Pain After Sipuleucel-T in Asymptomatic Patients with Metastatic Castrate-Resistant Prostate Cancer (mCRPC): Results from 3 Randomized Phase 3 Trials," abstract #4661. McCormick Place Hall A (Poster 12E) from 8:00 a.m. to 12:00 p.m. CT on Sunday, June 5, 2011.
  • "Quality of Life Assessment in Randomized, Double-Blind Study of Sipuleucel-T in Men with Androgen Dependent Prostate Cancer," abstract #4648. McCormick Place Hall A (Poster 10H) from 8:00 a.m. to 12:00 p.m. CT on Sunday, June 5, 2011.
  • "Post-Progression Treatment with APC8015F May Have Prolonged Survival of Subjects in the Control Arm of Sipuleucel-T Phase 3 Studies," abstract #4534. E450A from 2:00 to 6:00 p.m. CT on Saturday, June 4, 2011.
  • "Sipuleucel-T in African Americans: a Subgroup Analysis of Three Phase 3 Sipuleucel-T Trials in Advanced Prostate Cancer," abstract #E15148. Publication only.

PROVENGE was approved by the U.S. Food and Drug Administration (FDA) in April 2010 as the first autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.

"In addition to the significant survival benefit PROVENGE has demonstrated in Phase 3 clinical trials, the data analyses presented at the 2011 ASCO annual meeting provide further insight into the immunotherapy's potential impact on patient sub-groups, as well as clinically important factors like time to disease-related pain and quality of life," said Mark Frohlich, M.D., executive vice president of research and develop
'/>"/>

SOURCE Dendreon Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
3. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
4. Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
5. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
6. Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
7. Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial
8. Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial
9. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
10. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
11. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Dec. 22, 2014 TWi Biotechnology, Inc., ... Allowance for AC-201, TWi Biotechnology,s lead drug candidate, ... China for patent application numbered ... acceptable salts, active metabolite for treatment of type ... of treatment using AC-201 for type II diabetes, ...
(Date:12/19/2014)... Friday, December 19 edition of USA ... features Konica Minolta, the company announced today. The supplement will focus ... organizations. In addition to the print section that ... New York , Chicago , ... Minneapolis and San Francisco , a ...
(Date:12/19/2014)... 2014 TODAY, AEGATE, the leader ... announced the appointment of Peter Fox as ... Channels and Partner Officer. Peter has served ... its acquisition by Oracle in 2011. Prior ... Geneva and subsequently Convergys, a world renowned ...
Breaking Medicine Technology:TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 2TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 3USA Today Supplement Featuring Konica Minolta Focuses on Impact of Healthcare IT 2Aegate Appoints new CTO and Chief Channels & Partner Officer 2Aegate Appoints new CTO and Chief Channels & Partner Officer 3Aegate Appoints new CTO and Chief Channels & Partner Officer 4
... SEATTLE, May 30, 2012  Aequus BioPharma, Inc. ("Aequus"), a ... and MTA: CTIC), announced today that its GlycoPolymer technology ... AQB-101 drug candidate, was selected for an oral presentation ... The meeting will be held on May 28-30, 2012, ...
... Medical Center (DMC) and Henry Ford Health System (HFHS) ... renewal and bring jobs to the city of Detroit. ... As part of the economic recovery effort, DMC and ... Health, enabling the company to relocate a medical products ...
Cached Medicine Technology:Cell Therapeutics' Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs 2Cell Therapeutics' Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs 3Cell Therapeutics' Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs 4Cardinal Health, Detroit Medical Center, Henry Ford Health System Announce Unique Collaboration To Promote Urban Renewal 2Cardinal Health, Detroit Medical Center, Henry Ford Health System Announce Unique Collaboration To Promote Urban Renewal 3Cardinal Health, Detroit Medical Center, Henry Ford Health System Announce Unique Collaboration To Promote Urban Renewal 4
(Date:12/22/2014)... Explorys, the leader in big data-driven healthcare transformation, ... Yarrington as Vice President of Operations, Adam Wallace as ... President of Solutions. These new leaders are part of ... to support client demand for the company’s big data ... of its partner network. , Since the company ...
(Date:12/22/2014)... 2014 Only weeks following the announcement ... cities to have a battery manufacturer create 29 well-paying ... http://www.talklocal.com ) is launching in Henderson to deliver ... “A strong manufacturing sector is going to build a ... explained, “and TalkLocal works with small businesses that rely ...
(Date:12/22/2014)... Naples, Florida (PRWEB) December 22, 2014 ... this holiday season, the gift of health and vitality. ... is offering its three top-selling anti-aging formulas in special ... with free rush delivery. , Each bottle contains ... digestion, areas that don't work as well as we ...
(Date:12/22/2014)... In recognition of Veteran’s Day, Discount ... Reward, a local organization that provides services to veterans ... Located on a couple hundred acres in the hills ... world class fishing, hunting, hiking, horseback riding, 4-wheeling, skeet ... years ago to support U.S. Service men and women, ...
(Date:12/22/2014)... Atlanta, Georgia (PRWEB) December 22, 2014 The ... PartnerTech Inc, a wholly owned subsidiary of PartnerTech AB ... the U.S. having recently achieved additional ISO Certification. , All ... uptick in employment and the likelihood of a repeal of ... Care Act . The industry is anticipating annual growth of ...
Breaking Medicine News(10 mins):Health News:Explorys Continues to Experience Rapid Growth, Adds Three Healthcare IT Executives to Its Leadership Team 2Health News:Explorys Continues to Experience Rapid Growth, Adds Three Healthcare IT Executives to Its Leadership Team 3Health News:TalkLocal Launches in Henderson Weeks Following New Megafactory, New Jobs Announcement 2Health News:You Still Have Time to Give the Gift of Health and Vitality to a Mature Loved One 2Health News:Discount Labels Donates Portion of November Sales to Hero Reward Program 2Health News:PartnerTech Inc. Poised for Growth in MedTech 2
... is being issued by the National Press Club:(Logo: ... Club "AFTERNOON NEWSMAKER", Wednesday, April 15, 2009 - ... The Vice President of the Bureau of National ... DR. MICHAEL CHEN, will discuss, ...
... Community SafetyJEFFERSON CITY, Mo. , April 7 ... Parole has launched a new alcohol monitoring Pilot Program ... monitoring on the management of the state,s alcohol-fueled offenders. ... with a documented history of alcohol abuse and with ...
... and Head of Neurochemical Imaging in the Mood Disorders ... the first psychiatrist to be honoured with the Royal College ... , For over 30 years, scientists believed that monoamines ... are low in the brain during episodes of major depression. ...
... Technology Slashes Data Backup Size from 3.2 Terabytes to ... HoursHOPKINTON, Mass., April 7 EMC Corporation (NYSE: ... solutions, today announced that Harvard Vanguard Medical Associates, a ... more than 20 offices across eastern Massachusetts, has deployed ...
... April 7 HIMSS -- Infotech Global, Inc. (IGI) ... Meridian Health, a not-for-profit health system in Central New ... Universal Transfer Form (UTF). The draft UTF was tested ... version in 2008. This work was made possible through ...
... first sensor capable of measuring localized ultrasonic cavitation ... high frequency sound wave is applied. The sensor will ... before they are used on patients. The device recently ... Ultrasonic Industry Association. , Cavitation is used throughout ...
Cached Medicine News:Health News:Missouri DOC Conducting Pilot of 24/7 Alcohol Anklets 2Health News:Missouri DOC Conducting Pilot of 24/7 Alcohol Anklets 3Health News:Harvard Vanguard Cures Data Backup Ills With EMC Avamar 2Health News:Harvard Vanguard Cures Data Backup Ills With EMC Avamar 3Health News:Meridian Health Pilots Electronic Transfer Form 2Health News:Meridian Health Pilots Electronic Transfer Form 3Health News:I'm forever imploding bubbles 2
... CardioSEAL is a second generation device, ... was tested in over 700 patients beginning ... of leading pediatric cardiologists who perform these ... computer simulations, on the engineering bench, and ...
... YAG laser YC-1600 is a lightweight, compact, ... and clinical performance., ,Key Features, , ... Model ,Further weight reduction has been made ... office.,, Aiming Beam Rotation ,(360 degrees ...
... delivers a solid-state green laser ... and plugs into any standard ... and extreme portability, the unit ... Nidek Phaco Emulsification System CV-24000 ...
... is an effective angina relief ... poor targets. Because it is ... the CO2 Heart Laser 2 ... timely operative decisions to revascularize ...
Medicine Products: